Europe Diabetes Pen Market Latest Insights, Growth Rate, Future Trends and Forecast
The Europe
Diabetes Pen Market is expected to grow at a notable CAGR of 8.45% during
the forecast period between 2022 and 2030. Moreover, Market Research Future
(MRFR) forecasts that the global market will garner a valuation of USD 9.85
billion by the end of the forecast period.
Insulin is a hormone that is produced by the help of pancreas. However,
during diabetes, the pancreas fails to produce the requisite insulin for the
body. In order to inject insulin, a diabetes pen is required for the treatment
of diabetes. The product consists of an insulin cartridge, one which is either
integrated or bought separately, and a dial that is used to measure the dosage
level. This is used with disposable pen needles that helps deliver the dosage.
The high intake of sugar and carbs, increasing cases of obesity, and the
evolving consumer lifestyle are some of the major factors spreading the
prevalence of this disease.
Competitive Landscape
The Europe
Diabetes Pen Market comprises numerous players, including Becton, Dickinson
and Company (U.S.), AstraZeneca (U.K), Teruma Medical Corporation (Japan),
F. Hoffman La Roche AG (Switzerland), Greinier Bio One International GmBH
(U.S.), Bayer Cropscience Ltd. (Germany), and HTL STREFA SA (Poland). The
players are innovating with new products and consistently conducting research
and development activities to edge past the competition and strengthen their
global reach.
Market Segmentation
The Europe
Diabetes Pen Market segmentation is classified on the basis of usage,
distribution/sales channel, and product type.
·
By product type, the market divides into insulin pen needles and insulin pens.
·
By usage,
the market segments into disposable pens and reusable pens.
·
By distribution channel, the market comprises of online sales, retail pharmacy, hospital
pharmacy, and diabetes clinics.
Regional Analysis
The Europe
Diabetes Pen Market is geographically segmented into the following four major
regions: Asia Pacific, Europe, Americas, and the Middle East & Africa.
North America
holds the largest share of the Europe Diabetes Pen Market. Moreover, the region
is expected to garner consistent growth and expansion in the near future. The
factor influencing this positive growth trajectory of the market is the
presence of a large diabetic population, improved awareness of the consumers,
and the reimbursement policies for diabetes management. Add to this, continual
advancements in diabetes pen technology and increasing research and development
activities are also expected to drive the regional market of North America.
Europe is
the second-largest market in the global landscape and is expected to witness
negligible growth during the forecast period. Herein, the growth of the region
is attributed to the extensive usage of diabetes pen in the United Kingdom.
The Asia
Pacific region is another key market in the global scenario. The region is
positioned to grow in the fastest manner and cement its position as one of the
leading regional markets over the forecast period. The Asia Pacific region is
driven by the large pool of patients, improving awareness among the consumers,
evolving healthcare infrastructure, and the increasing expenditure in
healthcare. Additionally, new and innovative product launches and supportive
regulations imposed by the government help speed up the market growth in this
region. Countries like India, China, and Japan are expected to contribute
majorly to the success of the market.
India is
known to have a major percentage of people suffering from diabetes. Due to the
rising old-age population with diabetic conditions and an irregular change in
sugar levels, India is contributing significantly to the diabetes pen market.
Lastly, the
Middle East & Africa region is expected to attain steady and decent growth
owing to the increasing awareness among the consumers concerning
lifestyle-based diseases and the emergence of an influx of preventive measures
to tackle the elevated sugar levels of individuals.
Industry
News:
Feb 18th,
2019, Glooko, a diabetic’s data management organization, announced that its
latest Novo Nordisk connected insulin pens will be connected to the diasend
platform. The soon-to-be launched devices will be Novo Nordisk’s NovoPen 6 and
NovoPen Echo Plus.
Related
Report-
·
Dry Age-Related Macular Degeneration
Market
·
Global Endoprosthesis Market
About
Market Research Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients. Our market research studies by products,
services, technologies, applications, end users, and market players for global,
regional, and country level market segments, enable our clients to see more,
know more, and do more, which help to answer all their most important
questions.
In order to
stay updated with technology and work process of the industry, MRFR often plans
& conducts meet with the industry experts and industrial visits for its
research analyst members.
Contact:
Market
Research Future
+1 646 845
9312
Comments
Post a Comment